Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

2.07
Delayed Data
As of Apr 17
 +0.10 / +5.08%
Today’s Change
1.25
Today|||52-Week Range
5.27
+38.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-40.5M-28.0M-39.6M--
 
 
 
 
Depreciation4.4M4.3M3.3M--
 
 
 
 
Total Other Cash Flow7.2M3.1M40.0M--
 
 
 
 
Funds From Operations-28.9M-20.5M3.7M--
 
 
 
 
Funds From/For Other Operating Expenses5.5M-2.3M4.3M--
 
 
 
 
Net Cash Flow - Operating Activities-34.4M-18.2M-612.0K--
 
 
 
 
 
InvestingIncrease In Investments-28.5M0.00-19.2M--
 
 
 
Decrease In Investments54.0M2.0M10.7M--
 
 
 
 
Capital Expenditures-496.0K-452.0K-1.8M--
 
 
 
 
Fixed Asset Disposal0.00425.0K16.0K--
 
 
 
Net Cash Flow Investing25.1M2.0M-10.3M--
 
 
 
 
 
FinancingShort Term Borrowings---6.1M0.00--
 
 
Long Term Borrowings--0.0015.0M--
 
 
Long Term Debt Reduction-5.6M0.00-5.8M--
 
 
 
Net Proceeds Stock Sale16.1M35.2M6.6M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.005.1M--
 
 
Other Uses - Financing0.0010.1M10.3M--
 
 
 
Net Cash Flow - Financing10.6M19.1M10.5M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash1.2M2.8M-409.0K0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account